Global Blood Therapeutics (GBT) Reports Q2 LPS of $0.58

Global Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($0.58), versus ($4.84) reported last year.

Cash and cash equivalents totaled $231.9 million at June 30, 2016 compared with $148.5 million at December 31, 2015.

For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• EXL closes $1 billion credit facility, up from $600 million